Counterfeit Pharmaceuticals

Mehr zum Buch

Counterfeit pharmaceuticals pose a significant threat to consumer health, often leading to serious consequences, including death. Despite efforts by the FDA to combat this issue, many U.S. consumers lack a clear understanding of what constitutes a counterfeit drug and the associated risks. Research indicates that while the overall risk of counterfeit medications in the U.S. is lower than in other countries, it remains a concern. A formal communication strategy is needed to educate the public about these dangers to enhance awareness and protect their long-term health.